Loading, please wait...
.webp&w=384&q=75){kind=logo}
Verifying...
Loading, please wait...
"Wherever the art of Medicine is loved, there is also a love of Humanity."
— Hippocrates
Created by Omnicuris — India's largest continuous medical education platform. An advanced clinical decision support Agent designed specifically to aid clinicians in India.
While general-purpose LLMs are powerful, clinical settings demand precision, context, and zero margin for error.
Instantly pull up precise mechanism of action, pharmacokinetics, and tailored dosing regimens—including hepatic and renal adjustments—without leaving your workflow.
Cross-reference multi-drug prescriptions instantly to flag severe contraindications, synergistic toxicities, or food-drug interactions customized to common Indian dietary habits.
Anticipate adverse drug reactions (ADRs) and get proactive monitoring strategies or patient counseling points to improve medication adherence.
Input complex patient symptoms and comorbidities to receive structured, evidence-based treatment pathways designed to optimize patient outcomes.
When a primary drug is unavailable, unaffordable, or contraindicated, quickly discover viable alternative therapies, biosimilars, or generic options common in the Indian market.
Act as a dynamic bedside co-pilot, analyzing patient data profiles on the fly to help you make critical triage, diagnostic, and therapeutic decisions faster.
Simulate a quick, informal peer-to-peer consultation. Bounce tricky diagnostic puzzles off AIRA to explore differential diagnoses or validate your clinical gut instinct.
Access standard operating procedures aligned with Indian medical bodies (like ICMR) alongside global frameworks, bridging the gap between standard care and resource-constrained settings.
Skip hours of reading medical literature; get bite-sized, verified summaries of the latest randomized controlled trials (RCTs) and meta-analyses to justify your clinical decisions.
What is the recommended protocol for managing chronic heart failure (HFrEF) as per the Cardiological Society of India (CSI)?
What are the risks of euglycemic DKA with SGLT2 inhibitors in Indian patients on low-carb or fasting diets?
Is empirical oral Azithromycin still recommended for mild community-acquired pneumonia given current Indian antimicrobial resistance patterns?
Check for interactions between Rifampicin (in ATT) and standard oral contraceptive pills.
Does Saroglitazar provide significant cardiovascular and hepatic benefits for Indian patients with Diabetic Dyslipidemia?
Suggest a safe, empirical oral antibiotic alternative for an uncomplicated UTI based on the latest ICMR guidelines.
What does the latest literature say about the efficacy of IV Ferric Carboxymaltose versus Iron Sucrose for severe anemia in Indian women?
Summarize the latest NVBDCP national guidelines for calculating fluid management in Dengue Hemorrhagic Fever.
Manage resistant hypertension in an elderly Indian patient with Stage 3b CKD, hyperuricemia, and a vegetarian diet high in potassium.
Provide a differential diagnosis for a 30yo female in Delhi presenting with acute high fever, severe polyarthralgia, and a maculopapular rash.
Which liver and vision parameters should be routinely monitored for a patient on first-line Anti-Tubercular Therapy (ATT)?
Should I adjust the dosage of Teneligliptin or Glimepiride for a diabetic patient with an eGFR of 45?
Are there significant risks when combining common Ayurvedic Ashwagandha supplements with Escitalopram?
What are the severe interactions between Acitrom (Nicoumalone) and Amiodarone?
What are the most cost-effective alternatives to Metformin for an Indian patient experiencing severe gastrointestinal distress?
Summarize recent Indian data on the recommended duration of dual antiplatelet therapy (DAPT) following a PCI.
What is the current NTEP (National Tuberculosis Elimination Programme) guideline for managing Multi-Drug Resistant TB (MDR-TB)?
Optimize the anti-diabetic and cardiac regimen for a 65-year-old with T2DM, HFpEF, and a history of a recent upper GI bleed on Acitrom.
AIRA is built upon state-of-the-art foundation models and backed by robust enterprise infrastructure, ensuring high reliability and enterprise-grade security for sensitive clinical interactions.
Join over 5 lakh+ registered practitioners who trust Omnicuris. Move from learning to real-time clinical decision support with AIRA.
AIRA (Artificial Intelligence Resident Assistant) by Omnicuris is India's leading AI-powered clinical decision support tool designed specifically for healthcare professionals. As the medical landscape becomes increasingly complex, AIRA serves as a dedicated clinical companion, helping Indian doctors navigate demanding daily routines with precision and confidence.
Built upon state-of-the-art foundation models, AIRA provides real-time, evidence-based guidance grounded in established international medical guidelines and authoritative literature. Whether you are investigating drug interactions, seeking treatment protocols for chronic heart failure, or looking for differential diagnoses for complex tropical diseases, AIRA delivers context-aware assistance at the point of care.
Omnicuris, as India's largest continuous medical education (CME) platform, supports over 5 lakh+ registered practitioners. AIRA is the natural evolution of our mission to improve patient outcomes through expert knowledge. By moving beyond asynchronous learning to real-time support, AIRA ensures that expert clinical intelligence is always accessible and provides a secure, enterprise-grade environment for clinical queries.
Key features include deep integration with accredited CME content, and strict adherence to verifiable medical sources to eliminate AI hallucinations. Join thousands of clinicians across India who are elevating their practice with AIRA, the intelligent clinical co-pilot.